Replimune Group, Inc.

REPL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 479 employees
168
SEC Filings
$12.06
Close 2026-08-07
479
Employees

Business Summary

Replimune Group, Inc. is a clinical-stage biotechnology company developing oncolytic immunotherapies for cancer treatment. Its proprietary RPx platform is based on an engineered HSV-1 backbone designed to maximize immunogenic cell death and systemic anti-tumor immune response. Lead product RP1 (vusolimogene oderparepvec) is being evaluated in melanoma and non-melanoma skin cancers, with a BLA submitted to the FDA in combination with nivolumab for anti-PD-1 failed advanced melanoma, granted priority review with a PDUFA date of July 22, 2025.

Latest Stock Quote

REPL 2026-08-07 $12.06 O:$13 H:$13.4 L:$11.42 Vol:8.9M VWAP:$12.262
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-05-222025-03-310001737953-25-000009EDGAR79K words
2024-05-162024-03-310001737953-24-000008EDGAR—
2023-05-182023-03-310001737953-23-000009EDGAR—
2022-05-192022-03-310001737953-22-000010EDGAR—
2021-05-202021-03-310001104659-21-069611EDGAR—
2020-06-032020-03-310001047469-20-003318EDGAR—
2019-06-282019-03-310001047469-19-003946EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-032025-12-310001628280-26-004805EDGAR55K words
2025-11-062025-09-300001628280-25-049884EDGAR—
2025-08-072025-06-300001737953-25-000013EDGAR—
2025-02-122024-12-310001737953-25-000004EDGAR—
2024-11-122024-09-300001737953-24-000015EDGAR—
2024-08-082024-06-300001737953-24-000013EDGAR—
2024-02-082023-12-310001737953-24-000004EDGAR—
2023-11-072023-09-300001737953-23-000017EDGAR—
2023-08-032023-06-300001737953-23-000013EDGAR—
2023-02-092022-12-310001737953-23-000005EDGAR—
2022-11-032022-09-300001737953-22-000023EDGAR—
2022-08-042022-06-300001737953-22-000014EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-100001104659-26-093042EDGAR—
2026-08-070001104659-26-092246EDGAR—
2026-07-310001104659-26-088857EDGAR—
2026-07-300001104659-26-088481EDGAR—
2026-02-030001104659-26-009510EDGAR2K words
2026-01-120001104659-26-002721EDGAR—
2025-11-060001104659-25-107438EDGAR—
2025-10-200001104659-25-100605EDGAR—
2025-09-180001104659-25-091066EDGAR—
2025-09-040001104659-25-087464EDGAR—

168 total filings indexed. 139 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

oncology immuno-oncology skin-cancer-(melanoma,-nmsc,-cscc,-mcc,-basal-cell-carcinoma,-angiosarcoma) solid-organ-transplant-recipients-with-skin-cancers recist-1.1 modified-recist-1.1 accelerated-approval-pathway-(fda) biologics-license-application-(bla) breakthrough-therapy-designation priority-review

Company Identity

CIK0001737953
TickerREPL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.replimune.com
Listed2018-07-20

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f298829a770481aff10820e3743fa252b4b208a49f74eb833fb8915c9c8c82d3
parent: ad14a8af0587ac38a44bf82770826066611256958fa917f313dc5e285ed8ecc0
content hash: e4e569b6a01b913ed5b547415b661406dadcc290f9a6e594b284e08df96b8386
signed: 2026-08-11T19:06:29.691Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up REPL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on REPL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/REPL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.